Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/21/1997US5679828 Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
10/21/1997US5679801 Antiinflammatory agents, antiasthmatics
10/21/1997US5679797 Retroviral protease inhibiting compounds
10/21/1997US5679790 Antibiotics, bactericides
10/21/1997US5679785 3'(2')-amino- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides, and a process for the preparation thereof
10/21/1997US5679782 Inhibit receptor binding activity of urokinase-type plasminogen activator
10/21/1997US5679717 Method for removing bile salts from a patient with alkylated amine polymers
10/21/1997US5679716 Administering xanthohumol
10/21/1997US5679715 Administering effective amount of (r)-(-)-n,2-dimethyl-n-2-propynylphenethylamine, commonly known as deprenyl; monoamine oxidase inhibitor
10/21/1997US5679714 Treatment of smoking addiction
10/21/1997US5679713 Pharmaceutical composition containing carbachol and other cholinergic substances
10/21/1997US5679712 Antiarrhythmia agents, treatment of cardiovascular, nervous system disorders
10/21/1997US5679711 Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents
10/21/1997US5679709 N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide or salts, used for reduction of b-cell produced self-antibodies
10/21/1997US5679707 Administering topically atleast one compound selected from prostaglandin i2, beraprost, carbacyclin, iloprost, ciprosten, nileprost, cicaprost and other derivatives of prostaglandin i2 or salts
10/21/1997US5679706 Combination of a potassium channel activator and an antiarrhythmic agent
10/21/1997US5679705 Triterpene derivatives with immunosuppressant activity
10/21/1997US5679704 Use of 2- (N-(2-aminoethyl)amino) acetic acid derivatives
10/21/1997US5679700 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
10/21/1997US5679695 Aryl and heteroaryl compounds having anti-retrovirus activity
10/21/1997US5679692 Unbridged bis-aryl carbinol derivatives, compositions and methods of use
10/21/1997US5679691 Use of a spin trap in a cosmetic or dermatological composition
10/21/1997US5679690 Solution consists of antithrombin argatroban, micelle forming agents such as cholic acid derivatives and one or more lipids
10/21/1997US5679689 Bactericides
10/21/1997US5679688 Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
10/21/1997US5679686 Antipsychotic method
10/21/1997US5679685 Accelerated release composition containing bromocriptine
10/21/1997US5679684 Intiinflammatory agents, antiarthritis agents, nervous system disorders, aids
10/21/1997US5679683 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/21/1997US5679682 Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
10/21/1997US5679680 α-substituted hydrazides having calpain inhibitory activity
10/21/1997US5679679 Nervous system disorders, antipsychotics
10/21/1997US5679678 Analgesic and antiinflammatory agents
10/21/1997US5679677 Cardiovascular disorders
10/21/1997US5679675 Bactericides
10/21/1997US5679674 Analgesics
10/21/1997US5679672 Anitarrhythmic agents
10/21/1997US5679671 Angiotensin 1-converting enzyme inhibitor, vasopressin antagonism and atrial nautriuretic peptide hydrolase inhibitor
10/21/1997US5679668 Method of controlling fertility in males with 20-substitute of steroids
10/21/1997US5679667 Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve
10/21/1997US5679666 Administering topically, systemically or intraocularly to a host steroids selected from pregnadien derivatives, hydroxyprogesterone and tetrahydrocortexolone
10/21/1997US5679665 Pharmaceutical formulation comprised of polymyxintrimethoprim and an anti-inflammatory drug for ophthalmic and otic topical use
10/21/1997US5679663 Hydrazides of phosphinic acid derivatives; used as anti-depressant and memory enhancement
10/21/1997US5679660 Pharmaceutical composition comprising diclofenac and cyclodextrin
10/21/1997US5679658 N,O-carbonxymethylchitosan for prevention of surgical adhesions
10/21/1997US5679656 Artificial tanning compositions comprising dihydroxyacetone/alkylpolysaccharides/fatty alcohols
10/21/1997US5679655 Method of treating lesions resulting from genital herpes with hyaluronic acid-urea pharmaceutical compositions
10/21/1997US5679651 Administering cytarabine
10/21/1997US5679650 Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
10/21/1997US5679649 Inducing anesthesia, sedation, analgesia, hypothermia and reduced stress by administering effective amount of adenosine, adenosine-mono, di or triphosphates
10/21/1997US5679648 Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides
10/21/1997US5679647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
10/21/1997US5679644 Methods of treating diseases using triterpenoid acid derivatives
10/21/1997US5679630 Protease-containing cleaning compositions
10/21/1997US5679555 Method of using ribozyme analogs having rigid, non-nucleotidic molecular linkers
10/21/1997US5679400 Intravascular stent and method
10/21/1997US5679394 Adjunct administration of particulate therapeutic or diagnostic agent and dwell-time enhancing agent
10/21/1997US5679393 Method of preparing fat fractions of vegetable origin enriched with unsaponifiable materials and use of said fractions for preparing cosmetic and/or pharmaceutical compositions, in particular dermatological compositions
10/21/1997US5679376 Diphenoxylate, loperamide, and derivatives as treatment for gastrointestinal disorders
10/21/1997US5679375 Method of treating ulcers with sulfated polysaccharides
10/21/1997US5679374 Dispersion of lipid vesicles capable of penetrating into layers of skin and containing antimicrobial agents, n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidyl)-n-dimethyl-n-hydro xyethylammonium iodide, antiinflammatory agents, retinol
10/21/1997US5679360 Substance P antagonist for the treatment of lichens, prurigo, pruritus
10/21/1997US5679358 Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields
10/21/1997US5679354 Vaccine having an iscom-like structure comprising at least one lipid and one saponin and being free of incorporated antigens
10/21/1997US5679352 Synthetic Haemophilus influenzae conjugate vaccine
10/21/1997US5679337 Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient
10/21/1997US5679335 Cyclic alkylmethylsiloxanes for skin care
10/21/1997US5679325 Lidocaine aerosol anaesthetic
10/21/1997US5679260 Process for simultaneously removing tumour necrosis factor α and bacterial lipopolysaccharides from an aqueous liquid
10/21/1997CA2030433C New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases
10/21/1997CA2016765C Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
10/21/1997CA2015049C Pharmaceutically efficacious pteridine derivatives
10/21/1997CA2007145C Antibiotic n-acetylbenanomicin b, and the production and uses thereof
10/21/1997CA1339505C 2-substituted coumaran derivatives
10/21/1997CA1339503C Method and composition for ameliorating the adverse effects of aging
10/21/1997CA1339502C Anti-cancer activity potentiator
10/19/1997CA2203177A1 Cosmetic compound made up of pasty fat compounds and volatile compounds
10/19/1997CA2203082A1 Anti-cariogenic activity of erythritol
10/18/1997CA2202958A1 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug
10/18/1997CA2202719A1 Hetero-linked phenylglycinolamides
10/18/1997CA2202704A1 Benzyloxy-substituted phenylglycinolamides
10/18/1997CA2202703A1 Novel pyridazino-, pyrimido-,pyrazino- and triazino-indoles
10/17/1997CA2202579A1 Heterocyclically substituted phenylglycinolamides
10/17/1997CA2202563A1 New arylacetamides
10/16/1997WO1997038134A1 Method for detecting a target compound using a nucleic acid ligand
10/16/1997WO1997038118A1 Defective viral vaccine particles obtained in vivo or ex vivo
10/16/1997WO1997038104A1 Il-6 mutein
10/16/1997WO1997038103A1 Il-6 mutein
10/16/1997WO1997038102A1 Multivalent and multispecific antigen-binding protein
10/16/1997WO1997038101A1 Scf analog compositions and methods
10/16/1997WO1997038100A1 Human cachexia associated protein
10/16/1997WO1997038095A1 Complex superoxide dismutase product
10/16/1997WO1997038085A2 Genes amplified in cancer cells
10/16/1997WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997WO1997038012A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997WO1997038009A1 Cyclic adhesion inhibitors
10/16/1997WO1997038008A1 6-substituted amino-4-oxa-1-azabicyclo[3,2,0] heptan-7-one deriv atives as cysteine protease inhibitors
10/16/1997WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997WO1997038004A1 Gene family associated with neurosensory defects
10/16/1997WO1997038002A1 Extracellular/epidermal growth factor-like protein
1 ... 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 6746 6747 6748 6749 6750 6751 6752 6753 6754 6755 ... 7860